Skip to main content

Smartphone-Based Acceptance and Commitment Therapy Aids Fibromyalgia

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 2, 2024.

By Lori Solomon HealthDay Reporter

FRIDAY, Aug. 2, 2024 -- Digital acceptance and commitment therapy (ACT) is safe and efficacious compared with daily digital symptom tracking for managing fibromyalgia, according to a study published online July 8 in The Lancet.

R. Michael Gendreau, M.D., Ph.D., from Gendreau Consulting in Poway, California, and colleagues randomly assigned 275 adult participants (aged 22 to 75 years) with fibromyalgia to either the digital ACT group (12-week, self-guided, smartphone-delivered digital ACT program) or an active control group that offered daily symptom tracking and monitoring and access to health-related and fibromyalgia-related educational materials.

The researchers found that at 12 weeks, 71 percent of ACT participants reported improvement on the patient global impression of change versus 22 percent of the active control participants. There were no reports of device-related safety events.

"Fibromyalgia options are typically limited to a handful of pharmacological interventions that have limited efficacy and that can come with difficult-to-manage side effects," coauthor Mike Rosenbluth, Ph.D., CEO of Swing Therapeutics, said in a statement. "This publication validates Stanza as a guideline-directed nondrug approach that many patients previously couldn’t access due to few available trained clinicians, geographic limitations, and cost."

Swing Therapeutics funded the study.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2024

Read this next

Global Prevalence of Congenital Heart Disease at High Altitude ~9 Percent

THURSDAY, Sept. 26, 2024 -- The global prevalence of congenital heart disease (CHD) at high altitude is 8.97 percent, according to the results of a review presented at the...

Federal Government to Offer More Free COVID-19 Tests

WEDNESDAY, Sept. 25, 2024 -- The U.S. government is offering another round of free COVID-19 tests, which will be available by the end of September. "U.S. households will be...

Socioeconomic Factors Increase Risk for Age-Related Macular Degeneration

WEDNESDAY, Sept. 25, 2024 -- Socioeconomic factors are linked to an increased risk for age-related macular degeneration (AMD), according to a study published online July 1...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.